Literature DB >> 29804024

Prognostic value of pre-operative neutrophil/lymphocyte ratio, monocyte count, mean platelet volume, and platelet/lymphocyte ratio in endometrial cancer.

Isa Temur1, Umran Kucukgoz Gulec2, Semra Paydas3, Ahmet Baris Guzel1, Mete Sucu1, Mehmet Ali Vardar1.   

Abstract

OBJECTIVE: Cancer-related inflammation is associated with poor long-term outcomes in various solid tumors. The aim of this study is to investigate the prognostic significance of pre-operative neutrophil lymphocyte ratio (NLR), monocyte count (MC), mean platelet volume (MPV), and platelet lymphocyte ratio (PLR) in endometrial cancer. STUDY
DESIGN: In this study, 763 patients with endometrial cancer were evaluated, who were followed between January 1996 and February 2016. Preoperative values of NLR, MC, MPV, and PLR were evaluated in terms of clinico-pathologic prognostic factors and overall survival (OS).
RESULTS: NLR, MC, and PLR were detected to be statistically significant with regard to advanced stage of the disease (p = 0.001, p = 0.02, and p = 0.001, respectively), but only MC was significant in terms of grade (p = 0.035). Higher NLR and PLR values were found to be associated with advanced stage of the disease, deep myometrial invasion, cervical involvement, lymphovascular space invasion (LVSI), and nodal involvement. When the cut-off value was considered as 3, sensitivity and specificity for NLR were found to be 68% and 69%, respectively, to predict lymph node metastasis. NLR was found as a prognostic factor for survival (p = 0.01). Age, the presence of comorbidity, stage, and cervical involvement were determined to be independent prognostic factors for OS in our cohort.
CONCLUSION: NLR was detected to be a prognostic factor for survival. Moreover, NLR and PLR are a predictive value for lymph node involvement and also for cervical invasion in endometrial cancer.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  Endometrial cancer; Mean platelet volume; Monocyte; Neutrophil lymphocyte ratio; Platelet lymphocyte ratio; Prognostic factor; Survival

Mesh:

Year:  2018        PMID: 29804024     DOI: 10.1016/j.ejogrb.2018.05.028

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  9 in total

Review 1.  Circulating Transcripts and Biomarkers in Uterine Tumors: Is There a Predictive Role?

Authors:  Christine De Bruyn; Thaïs Baert; Thierry Van den Bosch; An Coosemans
Journal:  Curr Oncol Rep       Date:  2020-01-29       Impact factor: 5.075

2.  Prognostic Significance of Pretreatment Neutrophil-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, or Monocyte-to-Lymphocyte Ratio in Endometrial Neoplasms: A Systematic Review and Meta-analysis.

Authors:  Jiali Leng; Fei Wu; Lihui Zhang
Journal:  Front Oncol       Date:  2022-05-16       Impact factor: 5.738

3.  Metabolic parameters with different thresholds for evaluating tumor recurrence and their correlations with hematological parameters in locally advanced squamous cell cervical carcinoma: an observational 18F-FDG PET/CT study.

Authors:  Siyao Du; Hongzan Sun; Si Gao; Jun Xin; Zaiming Lu
Journal:  Quant Imaging Med Surg       Date:  2019-03

4.  Combination of preoperative neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and monocyte-lymphocyte ratio: a superior prognostic factor of endometrial cancer.

Authors:  Rong Cong; Fanfei Kong; Jian Ma; Qing Li; Qijun Wu; Xiaoxin Ma
Journal:  BMC Cancer       Date:  2020-05-24       Impact factor: 4.430

5.  The systemic immune-inflammation index (SII) is an independent prognostic parameter of survival in patients with invasive vulvar cancer.

Authors:  Thomas Bartl; Christine Bekos; Magdalena Postl; Reinthaller Alexander; Stephan Polterauer; Aust Stefanie; Schwameis Richard
Journal:  J Gynecol Oncol       Date:  2020-10-21       Impact factor: 4.401

6.  Pre-treatment inflammatory parameters predict survival from endometrial cancer: A prospective database analysis.

Authors:  Kelechi Njoku; Neal C Ramchander; Y Louise Wan; Chloe E Barr; Emma J Crosbie
Journal:  Gynecol Oncol       Date:  2021-11-19       Impact factor: 5.482

7.  Predictive and prognostic values of preoperative platelet parameters in patients with gynecological tumors.

Authors:  Wei Yang; Ying-Ying Chen; Chen Bi; Kuang-Yi Shu; Man-Li Ye; Fan-Fan Li; Jie Chen; Xiao-Ou Wang; Xiao-Jian Chen; Ming-Hua Jiang
Journal:  J Clin Lab Anal       Date:  2020-03-13       Impact factor: 2.352

8.  May the change of platelet to lymphocyte ratio be a prognostic factor for T3-T4 laryngeal squamous cell carcinoma: A retrospective study.

Authors:  Bing Zhong; De-Ying Gu; Jin-Tao Du; Fei Chen; Ya-Feng Liu; Shi-Xi Liu
Journal:  PLoS One       Date:  2018-12-31       Impact factor: 3.240

Review 9.  Endometrial Cancer Immune Escape Mechanisms: Let Us Learn From the Fetal-Maternal Interface.

Authors:  Valentina Bruno; Giacomo Corrado; Denisa Baci; Benito Chiofalo; Maria Antonia Carosi; Livia Ronchetti; Emilio Piccione; Adriana Albini; Douglas M Noonan; Giulia Piaggio; Enrico Vizza
Journal:  Front Oncol       Date:  2020-03-12       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.